These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 7912240

  • 1. Expression of the multidrug resistance gene (MDR1) in non-small cell lung cancer.
    Abe Y, Nakamura M, Ota E, Ozeki Y, Tamai S, Inoue H, Ueyama Y, Ogata T, Tamaoki N.
    Jpn J Cancer Res; 1994 May; 85(5):536-41. PubMed ID: 7912240
    [Abstract] [Full Text] [Related]

  • 2. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer.
    Ota E, Abe Y, Oshika Y, Ozeki Y, Iwasaki M, Inoue H, Yamazaki H, Ueyama Y, Takagi K, Ogata T.
    Br J Cancer; 1995 Sep; 72(3):550-4. PubMed ID: 7669560
    [Abstract] [Full Text] [Related]

  • 3. Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas.
    Holzmayer TA, Hilsenbeck S, Von Hoff DD, Roninson IB.
    J Natl Cancer Inst; 1992 Oct 07; 84(19):1486-91. PubMed ID: 1359152
    [Abstract] [Full Text] [Related]

  • 4. Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer.
    Shin HJ, Lee JS, Hong WK, Shin DM.
    Anticancer Res; 1992 Oct 07; 12(2):367-70. PubMed ID: 1374598
    [Abstract] [Full Text] [Related]

  • 5. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
    Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB.
    Proc Natl Acad Sci U S A; 1990 Sep 07; 87(18):7160-4. PubMed ID: 1976252
    [Abstract] [Full Text] [Related]

  • 6. Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates.
    Poupon MF, Arvelo F, Goguel AF, Bourgeois Y, Jacrot M, Hanania N, Arriagada R, Le Chevalier T.
    J Natl Cancer Inst; 1993 Dec 15; 85(24):2023-9. PubMed ID: 7902445
    [Abstract] [Full Text] [Related]

  • 7. A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene.
    Barrand MA, Heppell-Parton AC, Wright KA, Rabbitts PH, Twentyman PR.
    J Natl Cancer Inst; 1994 Jan 19; 86(2):110-7. PubMed ID: 7903701
    [Abstract] [Full Text] [Related]

  • 8. Association between p53 mutation and clinicopathological features of non-small cell lung cancer.
    Guang SG, Ogura T, Sekine I, Yokozaki M, Esumi H, Kodama T, Nagai K.
    Jpn J Clin Oncol; 1997 Aug 19; 27(4):211-5. PubMed ID: 9379505
    [Abstract] [Full Text] [Related]

  • 9. [Relationship of mdr1 gene expression and multidrug resistance of primary lung cancer].
    Bai L, Sun Y, Li S.
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Feb 19; 20(1):30-2. PubMed ID: 10072799
    [Abstract] [Full Text] [Related]

  • 10. [Analysis of MDR1 (multidrug resistance) gene expression by RT-PCR].
    Nakashima A, Okabayashi T, Nakatani S, Kataoka M, Johira H, Takeda A, Orita K.
    Gan To Kagaku Ryoho; 1993 Apr 19; 20(6):831-3. PubMed ID: 8387754
    [Abstract] [Full Text] [Related]

  • 11. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
    Chen QY, Jiang ZY, Wu LJ, Zhang BY, Lu GH, Zhou JY.
    Zhonghua Zhong Liu Za Zhi; 2010 Apr 19; 32(4):278-82. PubMed ID: 20510079
    [Abstract] [Full Text] [Related]

  • 12. [Correlation of the expression of III β-tubulin and MDR1 protein with biological features of non-small cell lung cancer].
    Hu LH, Wu Y, Lu GH, Chen QY, Wang YH, Zhou JY.
    Zhonghua Zhong Liu Za Zhi; 2010 Oct 19; 32(10):762-6. PubMed ID: 21163067
    [Abstract] [Full Text] [Related]

  • 13. Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay.
    Clifford SC, Thomas DJ, Neal DE, Lunec J.
    Br J Cancer; 1994 Apr 19; 69(4):680-6. PubMed ID: 7908215
    [Abstract] [Full Text] [Related]

  • 14. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J, Horáková I, Novotná H, Opáalka P, Roubková H.
    Clin Cancer Res; 1995 Mar 19; 1(3):359-65. PubMed ID: 9815992
    [Abstract] [Full Text] [Related]

  • 15. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component.
    Ohtsuka K, Ohnishi H, Fujiwara M, Kishino T, Matsushima S, Furuyashiki G, Takei H, Koshiishi Y, Goya T, Watanabe T.
    Cancer; 2007 Feb 15; 109(4):741-50. PubMed ID: 17238183
    [Abstract] [Full Text] [Related]

  • 16. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.
    Shaozhang Z, Xiaomei L, Aiping Z, Jianbo H, Xiangqun S, Qitao Y.
    Genes Chromosomes Cancer; 2012 Oct 15; 51(10):925-32. PubMed ID: 22736493
    [Abstract] [Full Text] [Related]

  • 17. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
    Staaf J, Isaksson S, Karlsson A, Jönsson M, Johansson L, Jönsson P, Botling J, Micke P, Baldetorp B, Planck M.
    Int J Cancer; 2013 May 01; 132(9):2020-31. PubMed ID: 23023297
    [Abstract] [Full Text] [Related]

  • 18. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH, Zhang SL, Li JL, Yap WS, Howe TC, Tan BP, Lee YS, Wong D, Khoo KL, Seto KY, Tan L, Agasthian T, Koong HN, Tam J, Tan C, Caleb M, Chang A, Ng A, Tan P.
    J Thorac Oncol; 2009 Jan 01; 4(1):12-21. PubMed ID: 19096301
    [Abstract] [Full Text] [Related]

  • 19. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D, Huang CL, Kameyama K, Hayashi E, Yamauchi A, Sumitomo S, Yokomise H.
    Cancer; 2002 Apr 15; 94(8):2239-47. PubMed ID: 12001123
    [Abstract] [Full Text] [Related]

  • 20. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L, Shan W, Zhang Y, Lv X, Li X, Wei C.
    Pathol Oncol Res; 2016 Jan 15; 22(1):161-7. PubMed ID: 26453197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.